IPO registrations (S-1, F-1) · Registrants
Scorpius Holdings, Inc.
- SEC CIK
- 1476963 · filings on EDGAR ↗
- Former names
- NightHawk Biosciences, Inc. (2022–2024); HEAT BIOLOGICS, INC. (2009–2022)
- Registration
- Form S-1, first filed 2013-05-06, last 2025-01-21; 9 initial registrations, 21 amendments
- Outcome
- Final prospectus filed 2013-07-24; declared effective 2013-07-23; withdrawal requested 2017-11-22
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1305 E. HOUSTON STREET, BUILDING 2, San Antonio, TX 78205
- EIN
- 26-2844103
- EDGAR entity type
- operating
- Insiders and CEO pay
- Scorpius Holdings, Inc. on the corporate pages
On this site
- Business registration: NIGHTHAWK BIOSCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: SCORPIUS HOLDINGS LLC Fuzzy (name and state)
- Form 5500 plan sponsor: NIGHTHAWK BIOSCIENCES, INC EXACT (EIN (EXACT))
- Form D issuer: Scorpius Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: HEAT BIOLOGICS, INC. EXACT (CIK (EXACT))
Filings 57
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-05-06 | S-1 | S-1 (registration) | HEAT BIOLOGICS, INC. | 0001553350-13-000103 ↗ |
| 2013-05-30 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-13-000237 ↗ |
| 2013-06-10 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-13-000268 ↗ |
| 2013-06-21 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-13-000286 ↗ |
| 2013-07-08 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-13-000347 ↗ |
| 2013-07-23 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-13-002161 ↗ |
| 2013-07-24 | 424B4 | 424B4 (final prospectus) | HEAT BIOLOGICS, INC. | 0001553350-13-000441 ↗ |
| 2014-10-23 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-14-003132 ↗ |
| 2016-01-21 | S-1 | S-1 (registration) | HEAT BIOLOGICS, INC. | 0001553350-16-001476 ↗ |
| 2016-02-19 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-16-001597 ↗ |
| 2016-02-26 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-16-001650 ↗ |
| 2016-03-09 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-16-001684 ↗ |
| 2016-03-15 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-16-001701 ↗ |
| 2016-03-17 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-16-003974 ↗ |
| 2016-03-18 | S-1MEF | S-1MEF (added securities) | HEAT BIOLOGICS, INC. | 0001553350-16-001727 ↗ |
| 2016-03-21 | 424B4 | 424B4 (final prospectus) | HEAT BIOLOGICS, INC. | 0001553350-16-001734 ↗ |
| 2017-01-05 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-17-000031 ↗ |
| 2017-09-15 | S-1 | S-1 (registration) | HEAT BIOLOGICS, INC. | 0001553350-17-001036 ↗ |
| 2017-10-10 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-17-001086 ↗ |
| 2017-10-17 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-17-001112 ↗ |
| 2017-10-19 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-17-002730 ↗ |
| 2017-11-13 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-17-002963 ↗ |
| 2017-11-22 | RW | RW (withdrawal request) | HEAT BIOLOGICS, INC. | 0001553350-17-001287 ↗ |
| 2018-03-30 | S-1 | S-1 (registration) | HEAT BIOLOGICS, INC. | 0001553350-18-000255 ↗ |
| 2018-04-19 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-18-000380 ↗ |
| 2018-04-26 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-18-000412 ↗ |
| 2018-05-02 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-18-000453 ↗ |
| 2018-05-02 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-18-000461 ↗ |
| 2018-05-02 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-18-000465 ↗ |
| 2018-05-02 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-18-001102 ↗ |
| 2018-05-04 | 424B4 | 424B4 (final prospectus) | HEAT BIOLOGICS, INC. | 0001553350-18-000475 ↗ |
| 2019-10-04 | S-1 | S-1 (registration) | HEAT BIOLOGICS, INC. | 0001553350-19-001031 ↗ |
| 2019-10-25 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-19-001090 ↗ |
| 2019-11-05 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-19-001125 ↗ |
| 2020-01-13 | S-1/A | S-1/A (amendment) | HEAT BIOLOGICS, INC. | 0001553350-20-000028 ↗ |
| 2020-01-16 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-20-000098 ↗ |
| 2020-01-17 | 424B4 | 424B4 (final prospectus) | HEAT BIOLOGICS, INC. | 0001553350-20-000068 ↗ |
| 2020-05-04 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-20-001026 ↗ |
| 2020-12-11 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-20-003492 ↗ |
| 2020-12-22 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-20-003632 ↗ |
| 2020-12-22 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-20-003633 ↗ |
| 2021-06-17 | EFFECT | EFFECT (declared effective) | HEAT BIOLOGICS, INC. | 9999999995-21-002411 ↗ |
| 2024-05-03 | S-1 | S-1 (registration) | Scorpius Holdings, Inc. | 0001079973-24-000643 ↗ |
| 2024-05-13 | S-1/A | S-1/A (amendment) | Scorpius Holdings, Inc. | 0001079973-24-000681 ↗ |
| 2024-05-13 | S-1MEF | S-1MEF (added securities) | Scorpius Holdings, Inc. | 0001079973-24-000699 ↗ |
| 2024-05-13 | EFFECT | EFFECT (declared effective) | Scorpius Holdings, Inc. | 9999999995-24-001517 ↗ |
| 2024-05-16 | 424B4 | 424B4 (final prospectus) | Scorpius Holdings, Inc. | 0001079973-24-000748 ↗ |
| 2024-05-16 | 424B4 | 424B4 (final prospectus) | Scorpius Holdings, Inc. | 0001079973-24-000753 ↗ |
| 2024-07-19 | S-1 | S-1 (registration) | Scorpius Holdings, Inc. | 0001079973-24-001079 ↗ |
| 2024-08-01 | S-1/A | S-1/A (amendment) | Scorpius Holdings, Inc. | 0001079973-24-001141 ↗ |
| 2024-08-06 | EFFECT | EFFECT (declared effective) | Scorpius Holdings, Inc. | 9999999995-24-002436 ↗ |
| 2024-08-16 | 424B4 | 424B4 (final prospectus) | Scorpius Holdings, Inc. | 0001079973-24-001276 ↗ |
| 2024-12-18 | S-1 | S-1 (registration) | Scorpius Holdings, Inc. | 0001079973-24-001699 ↗ |
| 2024-12-20 | EFFECT | EFFECT (declared effective) | Scorpius Holdings, Inc. | 9999999995-24-003909 ↗ |
| 2024-12-27 | S-1 | S-1 (registration) | Scorpius Holdings, Inc. | 0001079973-24-001781 ↗ |
| 2025-01-21 | S-1/A | S-1/A (amendment) | Scorpius Holdings, Inc. | 0001079973-25-000108 ↗ |
| 2025-04-28 | RW | RW (withdrawal request) | Scorpius Holdings, Inc. | 0001079973-25-000695 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Belsky Paul | Director | 5 | 2013–2016 | ||
| Brightline Ventures III, LLC | TenPercentOwner | 2 | 2013 | ||
| CZAJKOWSKI MATTHEW E | Officer | Chief Financial Officer | 2 | 2013–2014 | |
| Deyev Vadim | Officer | Director of Applied Research | 1 | 2013 | |
| FW Heat Investors, L.P. | TenPercentOwner | 1 | 2013 | ||
| Harris Jennifer Lynn | Officer | VP Clinical/Regulatory Affairs | 1 | 2013 | |
| KHARITONOV MICHAEL | Director | 5 | 2013–2016 | ||
| MONAHAN JOHN J | Director | 13 | 2013–2022 | ||
| Orion Holdings V, LLC | TenPercentOwner | 2 | 2013–2014 | ||
| Seed-One Holdings VI, LLC | TenPercentOwner | 2 | 2013–2014 | ||
| Silberman Sandra | Officer | Chief Medical Officer | 1 | 2013 | |
| Smith Edward B III | Director; Director,TenPercentOwner | 14 | 2013–2022 | ||
| Wolf Jeffrey Alan | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 20 | 2013–2024 | |
| ARISTAR HEAT, LLC | TenPercentOwner | 2 | 2013–2015 | ||
| BRIGHTLINE CAPITAL MANAGEMENT, LLC | TenPercentOwner | 1 | 2013 | ||
| BRIGHTLINE GP, LLC | TenPercentOwner | 1 | 2013 | ||
| KHERA, NICK | TenPercentOwner | 1 | 2013 | ||
| BOCK LOUIS C | Director | 3 | 2013–2016 | ||
| Price Melissa | Officer | VP Clinical/Regulatory Affairs; VP of Product Development | 4 | 2013–2016 | |
| Goyal Anil K. | Officer | VP of Business Development | 3 | 2013–2016 | |
| Schreiber Taylor | Officer | Chief Scientific Officer; Vice President of Research | 5 | 2014–2016 | |
| ARISTAR CAPITAL MANAGEMENT GP, LLC | TenPercentOwner | 1 | 2015 | ||
| ARISTAR CAPITAL MANAGEMENT, LLC | TenPercentOwner | 1 | 2015 | ||
| DiPalma Stephen J. | Officer | Interim CFO | 1 | 2015 | |
| CREECH TIMOTHY J | Officer | Chief Financial Officer | 2 | 2015 | |
| Rosar Ann A | Officer | VP of Finance; VP of Finance and Controller | 7 | 2016–2019 | |
| PRENDERGAST JOHN K A | Director | 11 | 2016–2022 | ||
| Hutchins Jeff Tobin | Officer | Chief Scientific Officer; CSO and COO; CSO/COO | 6 | 2017–2020 | |
| Jakobs Robert James | Officer | VP Finance/Controller/Secty | 2 | 2019 | |
| Ostrander William L. | Officer | CFO/Corp Secy; VP Finance/Corp Secy | 7 | 2019–2022 | |
| Thuan Tan Sze | Director | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-02-18 | Scorpius Holdings, Inc. | Biotechnology | $1,000,000 | $1,000,000 | 1 | 1 |
| 2025-02-12 | Scorpius Holdings, Inc. | Biotechnology | $600,000 | $600,000 | 1 | 1 |
| 2024-12-11 | Scorpius Holdings, Inc. | Biotechnology | $13,388,889 | $13,388,889 | 2 | 1 |
| 2017-05-11 | HEAT BIOLOGICS, INC. | Biotechnology | $500,000 | $500,000 | 45 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.